argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update
Provided By GlobeNewswire
Last update: Jul 31, 2025
$949 million in second quarter global product net sales
VYVGART SC launch in CIDP progresses with more than 2,500 patients on treatment globally
Read more at globenewswire.com756.38
-7.14 (-0.94%)
Find more stocks in the Stock Screener
ARGX Latest News and Analysis
4 days ago - By: Chartmill
